Big start today then they put the brakes on again. Need some volume buyers. Seems cheap if they can get recruitment cracking and sell the story. Ignoring the usual bleating about the differences, no doubt in my mind that MSB approval will also boost cynata.
Ann: Strategic Review of Cynata Clinical Development Portfolio, page-13
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.005(1.85%) |
Mkt cap ! $49.39M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.5¢ | $6.183K | 22.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 32514 | 3 |
View Market Depth
| Last trade - 11.18am 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
27.5¢ |
Change
0.005 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| 28.0¢ | 28.0¢ | 27.0¢ | 21201 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| CYP (ASX) Chart |